Firebrick Pharma Limited ( FRE.AX) - Price History
Monthly price history for FRE.AX (Firebrick Pharma Limited)
| Date | Adjusted price | Real price |
|---|---|---|
| June 2026 | A$0.04 | A$0.04 |
| May 2026 | A$0.04 | A$0.04 |
| April 2026 | A$0.06 | A$0.06 |
| March 2026 | A$0.06 | A$0.06 |
| February 2026 | A$0.06 | A$0.06 |
| January 2026 | A$0.06 | A$0.06 |
| December 2025 | A$0.05 | A$0.05 |
| November 2025 | A$0.06 | A$0.06 |
| October 2025 | A$0.07 | A$0.07 |
| September 2025 | A$0.07 | A$0.07 |
| August 2025 | A$0.08 | A$0.08 |
| July 2025 | A$0.08 | A$0.08 |
| June 2025 | A$0.06 | A$0.06 |
| May 2025 | A$0.07 | A$0.07 |
| April 2025 | A$0.07 | A$0.07 |
| March 2025 | A$0.09 | A$0.09 |
| February 2025 | A$0.09 | A$0.09 |
| January 2025 | A$0.07 | A$0.07 |
| December 2024 | A$0.06 | A$0.06 |
| November 2024 | A$0.05 | A$0.05 |
| October 2024 | A$0.06 | A$0.06 |
| September 2024 | A$0.06 | A$0.06 |
| August 2024 | A$0.06 | A$0.06 |
| July 2024 | A$0.04 | A$0.04 |
| June 2024 | A$0.06 | A$0.06 |
| May 2024 | A$0.06 | A$0.06 |
| April 2024 | A$0.06 | A$0.06 |
| March 2024 | A$0.05 | A$0.05 |
| February 2024 | A$0.05 | A$0.05 |
| January 2024 | A$0.05 | A$0.05 |
| December 2023 | A$0.05 | A$0.05 |
| November 2023 | A$0.06 | A$0.06 |
| October 2023 | A$0.04 | A$0.04 |
| September 2023 | A$0.05 | A$0.05 |
| August 2023 | A$0.32 | A$0.32 |
| July 2023 | A$0.18 | A$0.18 |
| June 2023 | A$0.16 | A$0.16 |
| May 2023 | A$0.17 | A$0.17 |
| April 2023 | A$0.20 | A$0.20 |
| March 2023 | A$0.20 | A$0.20 |
| February 2023 | A$0.20 | A$0.20 |
| January 2023 | A$0.22 | A$0.22 |
| December 2022 | A$0.23 | A$0.23 |
| November 2022 | A$0.26 | A$0.26 |
| October 2022 | A$0.26 | A$0.26 |
| September 2022 | A$0.28 | A$0.28 |
| August 2022 | A$0.35 | A$0.35 |
| July 2022 | A$0.35 | A$0.35 |
| June 2022 | A$0.26 | A$0.26 |
| May 2022 | A$0.36 | A$0.36 |
| April 2022 | A$0.40 | A$0.40 |
| March 2022 | A$0.42 | A$0.42 |
| February 2022 | A$0.45 | A$0.45 |
| January 2022 | A$0.65 | A$0.65 |
FRE.AX
Price: A$0.04
52 week price:
Earnings Per Share: -0.01 AUD
P/E Ratio: -5.80
Exchange: ASX
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 14.6 million